Table 2.
Changes in the clinical data of study and control group participants over study periods.
| Dependent variables: mean (SD) | Group | Baseline | 1 week | 1 month | P value |
|---|---|---|---|---|---|
|
| |||||
| Pain score | AWCT | 8.8 (0.8) | 6.3 (1.1) | 5.7 (0.9) | 0.001 |
| Control | 8.6 (1.2) | 7.1 (1.3) | 6.9 (1.02) | 0.06 | |
|
| |||||
| Joint swelling/joint tenderness | AWD | 2.1 (0.4) | 1.67 (0.13) | 1.1 (0.3) | 0.001 |
| Control | 2.3 (0.2) | 2.0 (0.7) | 2.1 (0.5) | 0.551 | |
|
| |||||
| Patient global assessment of response to treatment (PGART) | AWD | 81 (7) | 74 (3) | 67 (6) | −0.01 |
| Control | 79 (11) | 76 (9) | 80 (4) | −0.971 | |
|
| |||||
| HRQoL | AWD | 57 (16) | 61 (11) | 69 (7) | 0.01 |
| Control | 54 (13) | 57 (17) | 56 (15) | 0.819 | |
|
| |||||
| Sleep quality | AWD | 16 (3.1) | 14 (1.8) | 11 (0.5) | 0.01 |
| Control | 15.4 (4.3) | 14.7 (1.8) | 15.0 (0.9) | 0.907 | |
|
| |||||
| Serum uric acid (mg/dl) | AWCT | 9.9 (1.4) | 8.1 (0.9) | 7.2 (1.1) | 0.05 |
| Control | 9.67 (2.1) | 8.7 (1.8) | 8.13 (2.2) | 0.653 | |